[ad_1]
As the coronavirus mutant continues to find loopholes to spread and infect as many people as possible around the world, those affected are trying to reassure everyone that the vaccines are very effective, but they insist the need to adhere to precautionary measures so that people avoid any trickery of the epidemic.
And while the World Health Organization expected the Delta to mutate from the Corona virus, which is highly contagious and is currently responsible for more than 75% of new infections in a number of large countries, the strain la more dominant in the coming months, Anthony Fauci, the chief infectious disease expert in the United States, in fact admitted in a hearing in the United States Senate that the Delta strain is the cause of more than 80% of new case of infection in America.
However, he reiterated that approved vaccines are still over 90% effective in reducing hospitalization rates and deaths.
In the midst of these developments and unrest, Al Arabiya.net contacted Dr Mazen Zuwaihid, head of the Department of Lung Disease and Critical Care at the American University Hospital in Dubai, who holds a bachelor’s degree in medicine and surgery from the University of Damascus in Syria. , then a degree in internal medicine from Case University in the United States of America, which has already made it clear that the new mutations in the Corona virus spread very quickly and to a much greater extent than normal strains.
He also revealed that the vaccines are always effective against it, as they do not completely prevent infection, but rather prevent difficult symptoms after infection, as the disease occurs in the vaccinated person much milder than the unvaccinated.
mutated crown
He explained that the symptoms of those vaccinated are accompanied by upper respiratory syndrome, and infections often do not reach the lungs.
He pointed out that the new “Delta” strain is in fact the fastest spread, explaining that Corona along with the Delta strain caused a big change in its properties and spread very quickly, and that the method of infection is became much easier, and perhaps Britain and America are the two best examples.
And the Chinese Sinopharm?
While a recent study conducted by one of the leading universities in Sri Lanka, accompanied by researchers from the University of Oxford, reported that the Chinese vaccine “Sinopharma” achieved a high efficacy of 95% against the delta variant, Zuhaid explained that Sinopharm is weaker than other vaccines against the new mutant, pointing out that Pfizer has reached a higher percentage.
He added that there were patients who received the Sinopharm vaccine and contracted Corona, who had severe symptoms, compared to those who received Pfizer and were experiencing the same symptoms.
Chinese sinopharma vaccine
He also confirmed that with revaccination of people who received Sinopharm with two doses of Pfizer or at least one dose, as soon as 6 months have passed since the second dose of the Chinese vaccine.
Very good news about the new drug
As for the new drug, which the UAE’s Ministry of Health announced in early July, granting it emergency use, it largely confirmed the drug’s effectiveness against the emerging corona virus.
new medicine
He added that the new drug, produced by the global company GSK, had already proven effective, but with the first days of infection, that is, before the virus reached the lungs.
Golden stadium for real estate
He also continued that the drug is in its golden phase which can eliminate the disease, but if the infection was discovered early and the drug was taken in the same period, do not wait after 5 days because the delay causes the virus to reach the lungs, and therefore the effectiveness of the drug may become almost nonexistent. .
He pointed out that recent studies and statistics were very, very promising on this new drug if the condition of its early use was implemented.
It should be noted that the United Arab Emirates had granted emergency use of the drug “Sotrovimab-VIR-7831”, which relies on “monoclonal antibodies” to treat patients aged 12 years and over who are at high risk. to develop severe symptoms of Covid-19 and hospitalization due to the after-effects of the disease.
New drug from drug giant GSK
The results were cited on the drug produced by the global company “GSK”, and it got approval and approval from the US Food and Drug Administration for emergency use.
It has been shown to be effective in the treatment of Covid-19 cases, and has helped reduce hospital stays, as well as reduce the death rate by 85%, after relying on monoclonal antibodies to treat patients aged 12 years and over, and to treat simple and moderate infections caused by the mutated virus and emerging mutations. .
Source link
